Sign In
Not register? Register Now!
Essay Available:
Pages:
4 pages/≈1100 words
Sources:
No Sources
Style:
APA
Subject:
Accounting, Finance, SPSS
Type:
Other (Not Listed)
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 18.72
Topic:

Johnson & Johnson's Financial Statement Analysis

Other (Not Listed) Instructions:

For this project you will be completing a financial statement analysis for Johnson & Johnson. All the materials that you will need in order to be able to conduct this analysis will be available to you on Brightspace. This project is due by 11:59 PM EST on April 1, 2022. You will be submitting a 4-5 page written paper (in PDF format), along with a spreadsheet (using the provided template) with: 1. The following financial statements for the firm (each in its own tab of the spreadsheet) a. 2021 Balance Sheet (this will include data from the 2019 Balance Sheet that you manually add) b. 2021 Income Statement c. 2021 Statement of Cash Flows 2. Ratio Analysis (in a separate tab on the spreadsheet) Please complete all calculations in your spreadsheet. You MUST use cell references. Points will be deducted for students not using Excel for calculations. Clearly label all worksheets in your spreadsheet so I can easily follow your work. Your written paper should include a brief introduction and conclusion and answer the questions below, using the calculations in your spreadsheet for support. Clearly state which items in your spreadsheet you are referring to in your paper (use the column letter and row number). Your written paper should include responses to the questions below. You should discuss and explain your financial analysis of Johnson & Johnson in your paper. Any assumptions must be clearly discussed in your paper. Using the financial statements of Johnson & Johnson, answer the following questions (your response must be clearly written in your paper)

Other (Not Listed) Sample Content Preview:

Financial Statement Analysis
Author
Affiliation
Course
Instructor
Due Date
Johnson & Johnson Financial Analysis
Johnson & Johnson is an American company founded in 1986 with its headquarters in New Jersey. The company develops and sells medical devices, drugs, pharmaceuticals, consumer goods. Johnson & Johnson's latest and biggest breakthrough is the development of the coronavirus vaccine (Johnson & Johnson, 2022). Johnson & Johnson's vaccine was unique from the other vaccine because it was a single-dose vaccine; unlike its counterparts such as Moderna, Pfizer, etc., Johnson & Johnson’s shares for part of the Dow Jones Industrial Average index. It is ranked at position thirty-six in the Fortune 500. The company is highly valuable and has exceptional credit ratings (Johnson & Johnson, 2022). The current Chief Executive Officer of the company is Joaquin Duato, who acts as the Chairman (Ozaist, 2022). The major products that can be identified with the company include first aid kits, bandages, Johnson's Baby products, Janssen Pharmaceuticals, etc. The company seems to be doing well financially as the financial statements reveal steady growth in sales and profits. The balance sheet of the company also suggests a healthy financial position. Our study shall explore the company's financial statements, looking into its performance. Since the company has a steady income and a healthy balance sheet, the company can pursue lease or hire purchase options, issue debentures, or preferred stocks as external financing options.
Income statement





Common Size Income Statement

 

 

 

 

 




Period Ending:

2021

2020

2019

2018

2021

2020

2019









Revenue

93,775

82,584

82,059

81,581

1

1

1

Cost of Revenue, Total

29,855

28,327

27,456

26,986

31.84%

34.30%

33.25%

Gross Profit

63,920

54,257

54,603

54,595

68.16%

65.70%

66.12%

Total Operating Expenses

70,999

66,087

64,731

63,582

75.71%

80.02%

78.38%

Selling/General/Admin. Expenses, Total

23,559

21,084

22,178

22,540

25.12%

25.53%

26.86%

Research & Development

14,714

12,159

11,355

10,775

15.69%

14.72%

13.75%

Interest Expense (Income) - Net Operating

(370)

(410)

(183)

394

-0.39%

-0.50%

-0.22%

Unusual Expense (Income)

5,141

5,428

1,456

1,826

5.48%

6.57%

1.76%

Other Operating Expenses, Total

(1,900)

(501)

2,469

1,061

-2.03%

-0.61%

2.99%

Operating Income

22,776

16,497

17,328

17,999

24.29%

19.98%

20.98%

Net Income Before Tax...
Updated on
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now:
Order

👀 Other Visitors are Viewing These APA Other (Not Listed) Samples: